Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07641634
Recruiting
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
Phase 1/2 · Australia, China, South Korea, Mexico · 13 sites
Registry update: 9 Oct 2026
NCT07864883
Recruiting
3D Modeling of Deep Endometriosis From Pelvic MRI
Not applicable · France · 1 site
Registry update: 8 Oct 2026
NCT06954480
Recruiting
Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer
Phase 2 · Germany, Spain, United Kingdom · 26 sites
Registry update: 22 May 2026
2025-521658-40-00
Recruiting
A first-in-human, dose finding study to evaluate the safety, tolerability and pharmacokinetics of EGL-003 in healthy volunteers followed by adults with autoimmune disease.
Phase 1 · Bulgaria, Germany, Poland · 18 sites
Registry update: 28 Aug 2026
NCT07621445
Recruiting
Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study
Not applicable · China · 1 site
Registry update: 2 Jun 2026
NCT06856837
Recruiting
- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases
Phase 2 · Austria, Germany · 23 sites
Registry update: 12 Dec 2025
NCT07461948
Recruiting
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
Phase 3 · United States · 1 site
Registry update: 10 Mar 2026
NCT07244042
Recruiting
Effects of Modified CIMT With and Without PNF
Not applicable · Pakistan · 1 site
Registry update: 24 Nov 2025
NCT07109986
Recruiting
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
Phase 1 · China · 1 site
Registry update: 23 Jan 2026
NCT06405087
Recruiting
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Phase 3 · Belgium, Bulgaria, Switzerland, Denmark, Spain, Ireland, Italy, Japan, South Korea, Netherlands, Poland, Portugal, Romania, Serbia, Taiwan, United States · 54 sites
Registry update: 9 Oct 2026
NCT07086820
Recruiting
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
Not applicable · Chile · 13 sites
Registry update: 29 Dec 2025
NCT06835049
Recruiting
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
Phase 2 · Switzerland · 8 sites
Registry update: 30 Dec 2025
NCT07223034
Recruiting
A Study of 177Lu-PSMA-617 in People With Gliomas
Phase 1 · United States · 7 sites
Registry update: 4 Jun 2026
NCT06992258
Recruiting
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Phase 2 · United States · 13 sites
Registry update: 15 Oct 2026
NCT07151378
Recruiting
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
Phase 3 · Germany · 10 sites
Registry update: 13 Jul 2026
NCT06351345
Recruiting
129 Xenon Imaging in Patients Treated With Sotatercept
Phase 2 · United States · 1 site
Registry update: 24 Feb 2026
NCT07162714
Recruiting
SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer
Phase 2 · China · 1 site
Registry update: 7 Aug 2026
NCT07082842
Recruiting
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
Phase 3 · China · 1 site
Registry update: 21 Apr 2026
NCT07359690
Recruiting
Multimodal Analysis of Endomyocardial Biopsies
Not applicable · Germany · 1 site
Registry update: 22 Jan 2026
NCT06671613
Recruiting
Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer
Not applicable · United States · 4 sites
Registry update: 10 Nov 2025

Ordered by registry start date. Freshness and sponsorship never change the order.